An Index of Barriers for the Implementation of Personalised Medicine and Pharmacogenomics in Europe

Publisher： Karger

E-ISSN： 1662-8063|17|5-6|287-298

ISSN： 1662-4246

Source： Public Health Genomics, Vol.17, Iss.5-6, 2014-11, pp. : 287-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

Pharmacogenetics in Europe: Barriers and Opportunities

By  

Public Health Genomics, Vol. 12, Iss. 3, 2009-02 ,pp. : 134-141

Karger

Access to resources Recommend Favorite

Assessment of the Pharmacogenomics Educational Environment in Southeast Europe

By  

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-10 ,pp. : 272-279

Karger

Access to resources Recommend Favorite

Stakeholder Analysis in Pharmacogenomics and Genomic Medicine in Greece

By  

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-09 ,pp. : 280-286

Karger

Access to resources Recommend Favorite

Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 329-337

Karger

Access to resources Recommend Favorite